From: The effect of quitting smoking on HDL-cholesterol - a review based on within-subject changes
Factor | Level | N b | Unweighted analysis | Inverse-variance weighted analysis | ||
---|---|---|---|---|---|---|
Mean (95% CI) | p c | Mean (95% CI) | p c | |||
Overall | Â | 94 | 0.107 (0.085 to 0.128) | <0.001 | 0.060 (0.044 to 0.075) | <0.001 |
Univariate models | Â | Â | Â | Â | Â | Â |
Periodd | <3 weeks | 21 | 0.102 (0.047 to 0.157) | 0.04 | 0.100 (0.032 to 0.169) | <0.001 |
 | 3 to <6 | 21 | 0.102 (0.063 to 0.141) |  | 0.082 (0.042 to 0.123) |  |
 | 6 to <13 | 20 | 0.157 (0.119 to 0.194) |  | 0.131 (0.094 to 0.168) |  |
 | 13 to <27 | 11 | 0.107 (0.057 to 0.158) |  | 0.108 (0.061 to 0.155) |  |
 | 27 to <52 | 1 | 0.100 (−0.068 to 0.268) |  | 0.094 (−0.221 to 0.409) |  |
 | 52+ weeks | 20 | 0.065 (0.027 to 0.102) |  | 0.041 (0.026 to 0.057) |  |
Time quite | <3 weeks | 23 | 0.101 (0.050 to 0.152) | NS | 0.083 (0.030 to 0.137) | 0.006 |
 | 3 to <6 | 20 | 0.115 (0.075 to 0.155) |  | 0.112 (0.069 to 0.154) |  |
 | 6 to <13 | 22 | 0.145 (0.109 to 0.181) |  | 0.111 (0.075 to 0.148) |  |
 | 13 to <27 | 9 | 0.099 (0.042 to 0.156) |  | 0.072 (0.036 to 0.109) |  |
 | 27 to <52 | 4 | 0.088 (0.003 to 0.173) |  | 0.058 (−0.004 to 0.121) |  |
 | 52+ weeks | 16 | 0.062 (0.020 to 0.105) |  | 0.040 (0.023 to 0.057) |  |
Models adjusted for time quit | Â | Â | Â | Â | Â | Â |
Max Agef | <50 years | 8 | 0.124 (0.047 to 0.201) | NS | 0.161 (0.072 to 0.250) | NS |
 | 50-70 years | 28 | 0.107 (0.071 to 0.144) |  | 0.065 (0.038 to 0.093) |  |
 | >70 years | 58 | 0.094 (0.063 to 0.125) |  | 0.080 (0.057 to 0.104) |  |
Sex | Male | 46 | 0.090 (0.060 to 0.121) | NS | 0.073 (0.046 to 0.099) | NS |
 | Female | 30 | 0.139 (0.094 to 0.184) |  | 0.123 (0.061 to 0.186) |  |
 | Combined | 18 | 0.095 (0.052 to 0.138) |  | 0.078 (0.050 to 0.107) |  |
Continent | N America | 49 | 0.121 (0.082 to 0.160) | NS | 0.055 (0.024 to 0.087) | NS |
 | Europe | 30 | 0.110 (0.075 to 0.146) |  | 0.096 (0.062 to 0.130) |  |
 | Asia | 13 | 0.067 (0.016 to 0.118) |  | 0.081 (0.050 to 0.112) |  |
 | Australia | 2 | 0.026 (−0.099 to 0.152) |  | 0.018 (−0.179 to 0.215) |  |
Timingg | <1990 | 26 | 0.119 (0.077 to 0.160) | NS | 0.049 (0.016 to 0.082) | 0.08 |
 | 1990-1999 | 58 | 0.100 (0.071 to 0.129) |  | 0.088 (0.065 to 0.110) |  |
 | 2000+ | 10 | 0.071 (0.012 to 0.130) |  | 0.077 (0.040 to 0.114) |  |
Study type | Observational | 16 | 0.094 (0.031 to 0.157) | NS | 0.086 (0.057 to 0.115) | NS |
 | RCT | 16 | 0.093 (0.042 to 0.145) |  | 0.090 (0.057 to 0.123) |  |
 | Other | 62 | 0.108 (0.073 to 0.143) |  | 0.067 (0.040 to 0.093) |  |
Product smoked | Any | 16 | 0.102 (0.056 to 0.148) | NS | 0.103 (0.072 to 0.133) | 0.09 |
 | Cigarettes | 67 | 0.102 (0.075 to 0.130) |  | 0.069 (0.047 to 0.091) |  |
 | Cigarettes only | 11 | 0.095 (0.035 to 0.155) |  | 0.092 (0.054 to 0.129) |  |
Validation of quitting | Yes | 48 | 0.113 (0.077 to 0.149) | NS | 0.088 (0.060 to 0.115) | NS |
 | No | 46 | 0.092 (0.059 to 0.125) |  | 0.075 (0.051 to 0.098) |  |
Constraint on diet/exercise | Stay same | 15 | 0.141 (0.089 to 0.193) | 0.09 | 0.191 (0.126 to 0.255) | 0.003 |
 | Improve | 9 | 0.135 (0.076 to 0.193) |  | 0.064 (0.036 to 0.092) |  |
 | No constraint | 70 | 0.087 (0.061 to 0.114) |  | 0.082 (0.066 to 0.099) |  |
Baseline HDL-C | 1st tertile | 34 | 0.111 (0.070 to 0.151) | NS | 0.101 (0.068 to 0.134) | 0.03 |
 | 2nd tertile | 25 | 0.131 (0.083 to 0.178) |  | 0.097 (0.048 to 0.147) |  |
 | 3rd tertile | 28 | 0.100 (0.064 to 0.135) |  | 0.084 (0.061 to 0.108) |  |
 | unknown | 7 | 0.044 (−0.030 to 0.118) |  | 0.042 (0.010 to 0.073) |  |
Baseline weight/BMIh | 1st tertile | 19 | 0.132 (0.066 to 0.199) | NS | 0.154 (0.042 to 0.267) | NS |
 | 2nd tertile | 28 | 0.073 (0.039 to 0.108) |  | 0.073 (0.048 to 0.098) |  |
 | 3rd tertile | 21 | 0.111 (0.060 to 0.163) |  | 0.112 (0.065 to 0.158) |  |
 | unknown | 26 | 0.120 (0.083 to 0.156) |  | 0.076 (0.047 to 0.105) |  |
Change in weight/BMIh | 1st tertile | 5 | 0.155 (0.077 to 0.232) | NS | 0.161 (0.092 to 0.230) | 0.06 |
 | 2nd tertile | 29 | 0.076 (0.031 to 0.121) |  | 0.074 (0.022 to 0.125) |  |
 | 3rd tertile | 51 | 0.100 (0.073 to 0.128) |  | 0.065 (0.041 to 0.089) |  |
 | unknown | 9 | 0.105 (0.041 to 0.170) |  | 0.104 (0.042 to 0.166) |  |
Baseline LDL-C | 1st tertile | 17 | 0.067 (0.001 to 0.132) | NS | 0.092 (0.045 to 0.139) | NS |
 | 2nd tertile | 16 | 0.132 (0.063 to 0.201) |  | 0.084 (0.017 to 0.150) |  |
 | 3rd tertile | 17 | 0.085 (0.039 to 0.130) |  | 0.071 (0.028 to 0.113) |  |
 | unknown | 44 | 0.110 (0.079 to 0.141) |  | 0.080 (0.054 to 0.106) |  |
Baseline Triglycerides | 1st tertile | 26 | 0.134 (0.085 to 0.184) | NS | 0.099 (0.017 to 0.181) | NS |
 | 2nd tertile | 13 | 0.108 (0.059 to 0.157) |  | 0.099 (0.034 to 0.163) |  |
 | 3rd tertile | 24 | 0.075 (0.027 to 0.123) |  | 0.079 (0.044 to 0.114) |  |
 | unknown | 31 | 0.096 (0.062 to 0.130) |  | 0.075 (0.050 to 0.099) |  |
Baseline Systolic BP | 1st tertile | 8 | 0.079 (0.015 to 0.142) | NS | 0.060 (0.006 to 0.115) | NS |
 | 2nd tertile | 7 | 0.117 (0.046 to 0.188) |  | 0.096 (0.058 to 0.134) |  |
 | 3rd tertile | 5 | 0.066 (−0.016 to 0.148) |  | 0.090 (0.056 to 0.125) |  |
 | unknown | 74 | 0.107 (0.079 to 0.135) |  | 0.075 (0.052 to 0.098) |  |
Baseline Diastolic BP | 1st tertile | 8 | 0.079 (0.015 to 0.142) | NS | 0.060 (0.006 to 0.115) | NS |
 | 2nd tertile | 7 | 0.117 (0.046 to 0.188) |  | 0.096 (0.058 to 0.134) |  |
 | 3rd tertile | 5 | 0.066 (−0.016 to 0.148) |  | 0.090 (0.056 to 0.125) |  |
 | unknown | 74 | 0.107 (0.079 to 0.135) |  | 0.075 (0.052 to 0.098) |  |